Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-219-9 | CAS number: 1314-11-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
No reproductive toxicity study with strontium oxide is available. Since strontium oxide completely dissolves upon contact and during the reaction with water andbased on the assumption that strontium is the moiety of concern,the toxicity to reproduction will be addressed only with existing data on the moiety strontium.
In a sub-chronic repeated dose toxicity study conducted with strontium chloride, no adverse effects on reproduction were reported. Thus, strontium oxide in all probability has also no potential to induce toxicity to reproduction.
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Strontium
No histological changes for uterus, ovaries, testes and prostate after the administration of up to and including 4800 ppm strontium chloride hexahydrate were observed in an sub-chronic oral repeated dose toxicity study OECD 408 (Kroes, 1977). The authors reported a NOAEL of 4800 ppm, which is equivalent to a strontium concentration of 157.7 mg/kg bw.
In accordance with regulation 1907/2006 (EC), Annex IX, Section 8.7.3, Column 1, an extended one generation reproductive toxicity study shall be proposed, only in case the available repeated dose toxicity studies (e.g. 28-day or 90-day studies) indicate adverse effects on reproductive organs or tissues or reveal other concerns in relation with reproductive toxicity. Sufficient weight of evidence is available to demonstrate an absence of reproductive toxicity and that testing on vertebrate animals in an extended one- generation reproductive toxicity study (OECD 443) with strontium oxide shall be omitted.
Strontium oxide
Strontium oxide is not expected to show adverse effects on reproduction, since the moiety of concern strontium has not shown adverse effects on sexual function and fertility parameters analysed in a relevant repeated dose toxicity study. Thus, strontium oxide in all probability has also no potential to induce adverse effects and is not to be classified according to regulation (EC) 1272/2008 as reproductive toxicant: fertility impairment.
An extended one generation reproductive toxicity test with strontium oxide is not required according to regulation 1907/2006 (EC), Annex IX, Section 8.7.3, Column 1. For further information on the toxicity of strontium, please refer to the relevant section in the IUCLID and CSR.
For the purpose of hazard assessment of strontium oxide, the point of departure for the most sensitive endpoint of strontium, as moiety of concern, will be used for the DNEL derivation. Thus, the NOAEL of 9.9 mg Sr/kg bw/day for the repeated dose toxicity will be used.
Effects on developmental toxicity
Description of key information
No developmental toxicity study with strontium oxide is available. Since strontium oxide completely dissolves upon contact and during the reaction with water andbased on the assumption that strontium is the moiety of concern,the developmental toxicity will be addressed only with existing data on the moiety strontium.
In a prenatal developmental toxicity study conducted with strontium dinitrate, no adverse effects were reported. Since the moiety of concern strontium did not induce adverse effects, strontium oxide in all probability has also no potential to induce developmental toxicity. However, since some limitation were noted in the prenatal developmental toxicity study and this study is not suitable for hazard or risk assessment purposes, a testing proposal for a prenatal developmental toxicity study with strontium oxide is included.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Strontium
In a prenatal developmental toxicity study performed by Landsdown (1972) strontium nitrate were administered to rats subcutaneously between pregnancy day 9 to 19. No maternal toxicity was observed up to doses of 200 mg/kg bw of strontium nitrate. Litter sizes were similar and the number of resorption sites was not increased. Therefore, no embryotoxicity was observed. According to the authors, the results indicate that high maternal doses of strontium nitrate (25, 50, 100 or 200 mg/kg bw/day; equivalent to 10.3, 20.7, 41.4, or 82.8 mg Sr/kg bw/day) were not teratogenic when given at a maximum period of bone development.
Strontium oxide
Since no developmental toxicity study is available for strontium oxide, information on the moiety of concern strontium will be used for the hazard assessment.
No adverse effects on development were noted in a prenatal developmental toxicity study conducted with strontium dinitrate. However, some limitations of the study design were reported and thus no final conclusion on risk assessment and classification for strontium oxide can be made. Thus, a testing proposal for a prenatal developmental toxicity study with strontium oxide is included.
Justification for classification or non-classification
No adverse effects were observed in a sub-chronic repeated dose toxicity study conducted with strontium chloride. Thus, strontium oxide in all probability has also no potential to induce adverse effects on reproduction.
As the moiety of concern strontium did not show any adverse effect in a prenatal developmental toxicity study, strontium oxide in all probability has also no potential to induce developmental toxicity.
However, since this study is not suitable for hazard or risk assessment purposes, no final conclusion on classification and labelling for strontium oxide can be drawn. A testing proposal for a prenatal developmental toxicity study is included.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.